Tuberculosis News and Research

Latest Tuberculosis News and Research

Community awareness can help fight tuberculosis

Pennsylvania Health Secretary Everette James today stressed the importance of increasing awareness of tuberculosis, or TB, and continuing efforts to control the infectious airborne disease that killed nearly 2 million people in 2008.

24 Mar 2010

FHI, Duke University Medical Center pertner to improve TB treatment

Family Health International, a nonprofit global health and development organization working to improve the lives of the world's most vulnerable people, recently joined the Tuberculosis Trials Consortium, an international body that researches new TB drugs and treatment strategies. The consortium is funded by the US Centers for Disease Control and Prevention. As part of the consortium, FHI is partnering with Duke University Medical Center to conduct clinical trials that aim to reduce the duration of TB treatment and lessen the side effects of TB drugs.

24 Mar 2010

TB prevalence more common among HIV patients and aged individuals

A study by the Barcelona Public Health Agency has revealed those sections of the population that are most vulnerable to tuberculosis. The research, published in the journal Respiratory Research, shows that the highest death rates from this disease are among those aged over 50 or infected with HIV.

24 Mar 2010

Senate briefing on World TB Day

A Senate briefing, Bringing Established Methods to Scale: New Perspectives in the Changing World of TB, to discuss TB and drug-resistant TB, including multidrug-resistant TB and extensively-drug resistant, the impact on global health and the current state of surveillance, diagnosis and treatment around the world.

24 Mar 2010

Opinion: Repurposing wastewater; expanding global fund; financing global health needs

In an Economic Times opinion piece, Jeffrey Sachs of the Earth Institute at Columbia University outlines what he sees as "two huge challenges facing" the Global Fund to Fight AIDS, Tuberculosis and Malaria:

24 Mar 2010

Administration official discusses Obama's commitment to Africa's food security in Reuters interview

Food security is central to President Barack Obama's Africa policy, "the administration's top official for Africa," Assistant Secretary of State Johnnie Carson, said in an interview with Reuters. "We want to see the food security initiative take on greater momentum as more African countries are drawn into this program," Carson said.

23 Mar 2010

Researchers develop new compound to inhibit HIV transmission

A compound that can inhibit the transfer of HIV from one cell to another has been developed by researchers at the Institut de Biologie Structurale Jean-Pierre Ebel.

22 Mar 2010

Tricking TB into suicidal self-poisoning

Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.

22 Mar 2010

Novel ways of killing TB causing bacteria discovered

Researchers at Albert Einstein College of Medicine of Yeshiva University have found two novel ways of killing the bacteria that cause tuberculosis (TB), a disease responsible for an estimated two million deaths each year. The findings, published in the March 21 online issue of Nature Chemical Biology, could lead to a potent TB therapy that would also prevent resistant TB strains from developing.

22 Mar 2010

Global malaria investments saving lives, more funds needed

A new study linking funding increases in the global fight against malaria to a drop in deaths from the disease also shows that resources from donor governments still fall short of those needed for maximum impact against the world's fourth-biggest killer of children, according to a global health policy analyst at international aid agency World Vision.

20 Mar 2010

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

During the Fifth Decennial International Conference on Healthcare-Associated Infections, the Society for Healthcare Epidemiology of America and the Association for Professionals in Infection Control and Epidemiology awarded their first Partnership in Prevention Award to the National Guard Health Affairs in Saudi Arabia.

20 Mar 2010

New WHO report estimates 440,000 MDR-TB cases worldwide in 2008

There were an estimated 440,000 cases of multidrug-resistant tuberculosis (MDR-TB) around the world in 2008 - one-third of which were fatal, according to a new WHO report on drug-resistant TB, the Los Angeles Times reports (Maugh, 3/19).

20 Mar 2010

Report highlights gains in malaria fight, documents need for more funding

Global funding for efforts to fight malaria, which stood at $2 billion at the end of 2009, have "helped to contain the disease," but is "far short of the estimated $6 billion required annually to expand" efforts to fight it, the Roll Back Malaria Partnership said on Thursday, Reuters reports. The statements came as the partnership released a report (.pdf) that examined a decade's worth of global funding for malaria and its impact on fighting the disease (Hardach, 3/18).

20 Mar 2010

NMA to discuss the impact of health care reform on health disparities

The National Medical Association, the nation's oldest and largest organization representing the interests of 30,000 African American physicians will hold a press conference to address health care reform legislation and its impact on health disparities.

19 Mar 2010

Global initiative for reducing time taken to introduce new combination TB treatments

Ahead of World TB Day, US Food and Drug Administration Commissioner Margaret Hamburg helped public and private sector partners launch a new collaboration to significantly accelerate the development of combination treatments for tuberculosis — and replace an almost 50-year-old drug regimen. Created by the Global Alliance for TB Drug Development, the Critical Path Institute, and the Bill & Melinda Gates Foundation, the initiative could potentially reduce the time it takes to introduce new combination TB treatments from as much as a quarter century to as few as six years.

19 Mar 2010

Media outlets interview Shah during life sciences conference in Seattle

USAID Administrator Rajiv Shah was in Seattle on Tuesday to speak at the annual Life Science Innovation Northwest conference, the Seattle Times' blog, "The Business of Giving," reports. The blog outlines the Obama administration's global health and development goals, including the six-year $63 billion Global Health Initiative (GHI), as well as some of the challenges facing Shah at USAID.

19 Mar 2010

BioSense Technologies' Z-Sense Differential Impedance Sensing diagnostic system rapidly identifies drug susceptibility

BioSense Technologies, a pioneer in the development of diagnostic systems for rapid drug susceptibility testing, announced today that it presented key scientific findings at the National Foundation for Infection Disease 2010 Annual Conference on Antimicrobial Resistance, held in Bethesda, MD in early February.

19 Mar 2010

FDA drafts new rules for testing, approving drug cocktails; Public-private partnership for TB treatment development launched

The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).

19 Mar 2010

WHO estimates 440 000 MDR-TB cases in 2008

In some areas of the world, one in four people with tuberculosis (TB) becomes ill with a form of the disease that can no longer be treated with standard drugs regimens, a World Health Organization (WHO) report says.

19 Mar 2010

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.

18 Mar 2010